|
|
 |
| |
|
|
|
|
Grant availability
Grants are made possible through the support of LifeCell Corporation. Grants are limited to up to $25,000 for a period of one year, and are made to the principal investigator. Studies may be either clinical (human) or pre-clinical (animal/bench).
Grant Guidelines
Grants are awarded to the institution and not to the individual. It is assumed that some of the resources required to conduct the project are available through the investigator’s institution. The research grant serves to provide supplemental support for personnel, equipment or services required to complete the research. It cannot be used toward salary support for the AHS member faculty. The award shall be used for direct costs only; indirect costs are not covered. Scanned copies of all necessary institutional approvals (IRB, RDC and/or IACUC) are required before any funds are released. This approval is not required at time of grant application.
Grants are based on the scientific merit of the project as well as the investigator’s capability and the likelihood that the project will be completed successfully. Considerations include the investigator’s experience, background, availability of patient material and other resources.
An abstract that summarizes the project and a financial report detailing how the grant money was spent must be submitted to the American Hernia Society (AHS) office by the end of one year’s time. In addition, it is expected that the results of the research be presented at the AHS Annual Conference in 2011. Any publication arising from research supported by this grant must have a notation describing funding source, recognizing both the American Hernia Society and LifeCell Corporation.
|
|
|
|
|
